Grass Valley, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)EROWID CENTER, founded in 2005, is a small nonprofit in the Mental Health sector that reported $704K in total revenue in fiscal year 2023. Expenses of $775K exceeded revenue, resulting in a 10% operating deficit.
To provide and facilitate access to objective, accurate, and non-judgmental information about psychoactive plants, chemicals, drugs, technologies, and related issues that affect the mind, body, and culture. Erowid Center supports and trains libraries, publishers, and other information distributors on issues related to our field. Further, it is Erowid Center's goal to support medical, legal, scientific, academic, and independent experts in developing and publishing related resources.
1. DrugsData Lab Drug Checking -- Erowid Center runs a laboratory drug checking program that analyzes the contents of street samples of psychoactive drugs, including: novel psychoactive substances...
1. DrugsData Lab Drug Checking -- Erowid Center runs a laboratory drug checking program that analyzes the contents of street samples of psychoactive drugs, including: novel psychoactive substances (NPS); stimulants and euphoric stimulants; psychedelics; research chemicals; street heroin; fentanyl; and other opioids; as well as commercial and counterfeit pharmaceuticals. Samples are tested at a licensed laboratory and the results are published online at DrugsData.org. Erowid's DrugsData project also collects, manages, reviews, and presents laboratory-testing results from other US and international organizations. This information is made publicly available to help harm-reduction efforts, medical personnel, researchers, and the public. In 2023, 2,396 samples were tested through this project and 250 unique substances were detected. These results were published alongside 982 samples tested by other organizations. An average of 35,000 result pages were viewed per day, with an average 14,000 unique visitors per day. Results were regularly published on social media to Erowid's more than 180,000 followers. Erowid continued its partnerships with research groups doing lab validation of on-site analytical tools such as compact FTIR and fentanyl and xylazine test strips. A portion of the expenses and revenue associated with DrugsData research are included in the Drug Trend & Novel Psychoactive Substance and Research program services described below.
2. Public Online Information Services -- Erowid Center develops, maintains, and provides free access to an online collection of more than 96,500 documents, images, and other media files related to...
2. Public Online Information Services -- Erowid Center develops, maintains, and provides free access to an online collection of more than 96,500 documents, images, and other media files related to psychoactive plants and drugs. The collection contains information, essays and articles authored by a broad spectrum of contributors including health care professionals, substance abuse counselors, toxicologists, chemists, therapists, law enforcement agents, lawyers, anthropologists, experiential experts, writers, media, educators, and the general public. Note that Erowid's Experience Reports project is tracked as a separate program service. Erowid also shared information via social media accounts on Twitter, Instagram, and Facebook.
3. Archiving of Historical Documents -- Erowid Center's mission includes collecting, organizing, and preserving resources about psychoactives for the historical record. In 2023, Erowid's primary...
3. Archiving of Historical Documents -- Erowid Center's mission includes collecting, organizing, and preserving resources about psychoactives for the historical record. In 2023, Erowid's primary document archiving project was the Shulgin Collection. Erowid made great progress in digitizing Alexander and Ann Shulgin's personal papers, audio recordings, and documents. Erowid also organized, identified, and created metadata for digitized files. By the end of the year, Erowid had created index entries for 35,000 scanned documents in the collection of around 200,000 total scanned items. Erowid Center maintains a physical space designed to allow processing of historical archive collections (organizing, scanning, photographing, and digitizing) as well as permanent storage of some library archives/collections.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $703,768 | $666,519 | +0.1% |
| Expenses | $775,164 | $778,248 | 0.0% |
| Net Income | $-71,396 | $-111,729 | -0.4% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| C Blomquist | Treasurer | 60.00 |
Officer
Director
|
$81,000 | $18,478 | $99,478 |
| B Lincoln | President | 60.00 |
Officer
Director
|
$81,000 | $18,478 | $99,478 |
| J Dumpert | Secretary | 1 |
Officer
Director
|
$0 | $0 | $0 |
| E Fenster | Director | 0.7 |
Director
|
$0 | $0 | $0 |
| S Moore | Director | 0.8 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $703,768 | $775,164 | $539,007 | $-71,396 |
| 2022 | $666,519 | $778,248 | $432,219 | $-111,729 |
| 2021 | $699,750 | $632,579 | $785,140 | $67,171 |
Compare EROWID CENTER with other nonprofits in California and across the country.